Comment on: A rare case of cortical blindness following vaccination against SARS-CoV-2

Comment on: A rare case of cortical blindness following vaccination against SARS-CoV-2

Bibliographic Details
Main Authors:	Josef Finsterer, Sounira Mehri
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Indian Journal of Ophthalmology
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2023;volume=71;issue=6;spage=2617;epage=2617;aulast=Finsterer

Similar Items

The nature and severity of SARS-CoV-2 vaccine side effects in athletes are highly dependent on study design
by: Josef Finsterer, et al.
Published: (2023-08-01)

SARS-CoV-2-related cardiovascular complications in the tropics
by: Josef Finsterer, et al.
Published: (2022-12-01)

Before blaming SARS-CoV-2 infection or vaccination for acute peripheral artery occlusion, rule out differential causes
by: Josef Finsterer, et al.
Published: (2023-09-01)

A rare case of cortical blindness following vaccination against SARS-CoV-2
by: Asmita Mahajan, et al.
Published: (2022-01-01)

Ophthalmologic compromise following SARS-CoV-2 vaccinations
by: Josef Finsterer
Published: (2022-11-01)

Hypophysitis or pituitary apoplexy following a SARS-CoV-2 vaccination
by: Josef Finsterer
Published: (2023-09-01)

SARS-CoV-2 vaccinations complicated by transverse myelitis
by: Josef Finsterer
Published: (2022-11-01)

Comment on: Neurological Manifestations Associated With SARS-CoV-2 in Children: A Case Series
by: Josef Finsterer
Published: (2022-08-01)

Rhabdomyolysis or Myositis following a SARS-CoV-2 Vaccination
by: Josef Finsterer, et al.
Published: (2023-07-01)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
by: Josef Finsterer, et al.
Published: (2022-11-01)

Stroke four days after vaccination with a vector-based SARS-CoV-2 vaccine
by: Josef Finsterer
Published: (2022-01-01)

Self-reported Side Effects of SARS-CoV-2 Vaccinations
by: Josef Finsterer, et al.
Published: (2024-04-01)

Side effects of SARS-CoV-2 vaccines should be assessed by unbiased professionals on-site
by: Josef Finsterer
Published: (2022-11-01)

Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination
by: Josef Finsterer, et al.
Published: (2023-09-01)

Recurrent transitory attacks with cytotoxic edema could benefit from thrombolysis
by: Josef Finsterer, et al.
Published: (2024-03-01)

Alternative etiologies of rhabdomyolysis must be ruled out before attributing it to bedding during surgery
by: Josef Finsterer, et al.
Published: (2024-03-01)

Before quadriparesis with dysphagia can be attributed to COVID-19, all differential causes must be excluded
by: Josef Finsterer, et al.
Published: (2024-01-01)

Caution when using valproate for seizures in POLG1 carriers
by: Sounira Mehri, et al.
Published: (2023-01-01)

A stroke in severe acute respiratory syndrome coronavirus 2 infected is not necessarily a COVID-stroke
by: Sounira Mehri, et al.
Published: (2023-01-01)

Pathogenicity of Variant m.13528A>G in MT-ND5 in Leber’s Hereditary Optic Neuropathy Is Unsupported
by: Josef Finsterer, et al.
Published: (2023-09-01)

Stroke thrombolysis or not for an intraventricular thrombus
by: Josef Finsterer, et al.
Published: (2023-03-01)

Commentary: Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes with an MT-TL1 m.3243A>G point mutation: neuroradiological features and their implications for underlying pathogenesis
by: Josef Finsterer, et al.
Published: (2023-04-01)

Acute messenger RNA-based SARS-CoV-2 vaccine–related meningitis/encephalitis is not uncommon
by: Josef Finsterer
Published: (2024-01-01)

Before Attributing Polyradiculitis to an Anti-SARS-CoV-2 Vaccine, Differential Etiologies need to be Ruled Out
by: Josef Finsterer
Published: (2022-11-01)

How Does SARS-CoV-2 Fragment the QRS?
by: Josef Finsterer
Published: (2022-06-01)

Vision, brain, and nerves affected by SARS-CoV-2
by: Josef Finsterer
Published: (2023-01-01)

The assessment and interpretation of published data on Guillain–Barre syndrome after SARS‐CoV‐2 vaccination requires care
by: Josef Finsterer
Published: (2023-12-01)

Consider alternative causes of death to SARS-CoV-2 vaccination-related guillain–Barre syndrome without dysautonomia
by: Josef Finsterer
Published: (2022-01-01)

Letter to the Editor: Anti-SARS-CoV-2 Vaccination-Related Polyradiculitis Requires Early Diagnosis and Treatment to Improve the Outcome
by: Josef Finsterer
Published: (2023-07-01)

Rule out differentials before blaming SARS-CoV-2
by: Josef Finsterer
Published: (2022-09-01)

The frequency of SARS-CoV-2 infection/vaccination-related chorea depends on the inclusion/exclusion criteria
by: Josef Finsterer, et al.
Published: (2023-12-01)

Alternative pathophysiologies must be ruled out before right middle cerebral artery ischemic stroke can be attributed to SARS-CoV-2 vaccination
by: Josef Finsterer
Published: (2023-01-01)

Persisting, unilateral tinnitus 22 days after first dose of an mRNA-based SARS-CoV-2 vaccine
by: Josef Finsterer, et al.
Published: (2022-01-01)

SARS‐CoV‐2‐related polyradiculitis must be preceded by PCR‐confirmed COVID‐19
by: Josef Finsterer
Published: (2023-04-01)

Re-infections with SARS-CoV-2 require a clarification of favourable risk factors
by: Josef Finsterer
Published: (2023-11-01)

SARS-CoV-2 may underlie NMDA-related autoimmune encephalitis and venous sinus thrombosis
by: Josef Finsterer
Published: (2023-06-01)

Before diagnosing SARS-CoV-2 vaccination-associated polyradiculitis, alternative explanations must be ruled out
by: Ana Claudia Fiorini, et al.
Published: (2024-01-01)

Prospective studies are required for assessing the outcome of a SARS-CoV-2 infection based on the symptoms at onset
by: Josef Finsterer
Published: (2023-12-01)

Being negative for SARS-CoV-2 after four weeks of coughing requires considerations of alternative causes
by: JOSEF FINSTERER
Published: (2023-06-01)

Comment on ‘MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report’
by: Josef Finsterer, et al.
Published: (2022-06-01)